TRVI
Trevi Therapeutics Inc.
$8.47
+$0.09(+1.07%)
63
Overall
--
Value
63
Tech
--
Quality
Market Cap
$992.48M
Volume
1.11M
52W Range
$2.36 - $9.92
Target Price
$20.36
Key Metrics Overview
| Market Cap | $992.48M | P/E Ratio | N/A |
| 52W High | $9.92 | 52W Low | $2.36 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | N/A | 52W Position | 80.8% |
| Overall Score | 63 | Value Score | -- |
| Quality Score | -- | Technical Score | 63 |
Growth Analysis
| EPS Current Est | $-0.39 | EPS Next Est | $-0.54 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
No data available
EBITDA (5Y)
No data available
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TRVI | $8.47 | +1.1% | 1.11M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |